Functional selectivity and classical concepts of quantitative pharmacology - PubMed

Affiliations

• PMID: 16803859
• DOI: 10.1124/jpet.106.104463

Review

Functional selectivity and classical concepts of quantitative pharmacology

Jonathan D Urban et al. J Pharmacol Exp Ther. 2007 Jan.

Abstract

The concept of intrinsic efficacy has been enshrined in pharmacology for half of a century, yet recent data have revealed that many ligands can differentially activate signaling pathways mediated via a single G protein-coupled receptor in a manner that challenges the traditional definition of intrinsic efficacy. Some terms for this phenomenon include functional selectivity, agonist-directed trafficking, and biased agonism. At the extreme, functionally selective ligands may be both agonists and antagonists at different functions mediated by the same receptor. Data illustrating this phenomenon are presented from serotonin, opioid, dopamine, vasopressin, and adrenergic receptor systems. A variety of mechanisms may influence this apparently ubiquitous phenomenon. It may be initiated by differences in ligand-induced intermediate conformational states, as shown for the beta(2)-adrenergic receptor. Subsequent mechanisms that may play a role include diversity of G proteins, scaffolding and signaling partners, and receptor oligomers. Clearly, expanded research is needed to elucidate the proximal (e.g., how functionally selective ligands cause conformational changes that initiate differential signaling), intermediate (mechanisms that translate conformation changes into differential signaling), and distal mechanisms (differential effects on target tissue or organism). Besides the heuristically interesting nature of functional selectivity, there is a clear impact on drug discovery, because this mechanism raises the possibility of selecting or designing novel ligands that differentially activate only a subset of functions of a single receptor, thereby optimizing therapeutic action. It also may be timely to revise classic concepts in quantitative pharmacology and relevant pharmacological conventions to incorporate these new concepts.

Similar articles

• Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.

  Capasso A, Sorrentino L. Capasso A, et al. Br J Pharmacol. 1997 Mar;120(6):1001-6. doi: 10.1038/sj.bjp.0700995. Br J Pharmacol. 1997. PMID: 9134209 Free PMC article.

• Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery.

  Correll CC, McKittrick BA. Correll CC, et al. J Med Chem. 2014 Aug 28;57(16):6887-96. doi: 10.1021/jm401677g. Epub 2014 Apr 29. J Med Chem. 2014. PMID: 24697360

• The role of conformational ensembles of seven transmembrane receptors in functional selectivity.

  Vaidehi N, Kenakin T. Vaidehi N, et al. Curr Opin Pharmacol. 2010 Dec;10(6):775-81. doi: 10.1016/j.coph.2010.09.004. Curr Opin Pharmacol. 2010. PMID: 20933468 Review.

• Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?

  Bissantz C, Bernard P, Hibert M, Rognan D. Bissantz C, et al. Proteins. 2003 Jan 1;50(1):5-25. doi: 10.1002/prot.10237. Proteins. 2003. PMID: 12471595

• Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.

  Stott LA, Hall DA, Holliday ND. Stott LA, et al. Biochem Pharmacol. 2016 Feb 1;101:1-12. doi: 10.1016/j.bcp.2015.10.011. Epub 2015 Oct 23. Biochem Pharmacol. 2016. PMID: 26478533 Review.

Cited by

• Ligand directed signaling differences between rodent and human κ-opioid receptors.

  Schattauer SS, Miyatake M, Shankar H, Zietz C, Levin JR, Liu-Chen LY, Gurevich VV, Rieder MJ, Chavkin C. Schattauer SS, et al. J Biol Chem. 2012 Dec 7;287(50):41595-607. doi: 10.1074/jbc.M112.381368. Epub 2012 Oct 19. J Biol Chem. 2012. PMID: 23086943 Free PMC article.

• Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling.

  Zhang NR, Planer W, Siuda ER, Zhao HC, Stickler L, Chang SD, Baird MA, Cao YQ, Bruchas MR. Zhang NR, et al. J Biol Chem. 2012 Dec 7;287(50):42019-30. doi: 10.1074/jbc.M112.405696. Epub 2012 Oct 19. J Biol Chem. 2012. PMID: 23086955 Free PMC article.

• Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates.

  Schmitt KC, Rothman RB, Reith ME. Schmitt KC, et al. J Pharmacol Exp Ther. 2013 Jul;346(1):2-10. doi: 10.1124/jpet.111.191056. Epub 2013 Apr 8. J Pharmacol Exp Ther. 2013. PMID: 23568856 Free PMC article. Review.

• Ligand-Dependent Conformational Transitions in Molecular Dynamics Trajectories of GPCRs Revealed by a New Machine Learning Rare Event Detection Protocol.

  Plante A, Weinstein H. Plante A, et al. Molecules. 2021 May 20;26(10):3059. doi: 10.3390/molecules26103059. Molecules. 2021. PMID: 34065494 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database